Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qt Imaging Holdings (QTI) Notes Payables (2022 - 2024)

Qt Imaging Holdings (QTI) reported Notes Payables of $5.4 million for Q2 2024, up 440.37% year-over-year from $1.0 million in Q3 2023, and up 667.2% on a QoQ basis from $705000.0 in Q4 2023.

Qt Imaging Holdings (QTI) has 3 years of Notes Payables data on file, last reported at $5.4 million in Q2 2024.

  • Quarterly Notes Payables rose 440.37% year-over-year to $5.4 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $5.4 million (up 440.37% YoY) and the FY2023 annual result came in at $705000.0, up 173.79% from the prior year.
  • Notes Payables climbed to $5.4 million in Q2 2024 per QTI's latest filing, from $705000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $5.4 million in Q2 2024 and bottomed at $225000.0 in Q3 2022.
  • The 3-year median for Notes Payables is $1.0 million (2023), against an average of $1.4 million.
  • The widest annual swing landed in 2023, when Notes Payables surged 173.79%; it then soared 440.37% in 2024.
  • Tracing QTI's Notes Payables over 3 years: stood at $257492.0 in 2022, then surged by 173.79% to $705000.0 in 2023, then surged by 667.2% to $5.4 million in 2024.
  • Per Business Quant, the three latest QTI Notes Payables figures stand at $5.4 million (Q2 2024), $705000.0 (Q4 2023), and $1.1 million (Q3 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Qt Imaging Holdings 67.06 Mn 67.06 Mn 2.67 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 5.41 Mn
Dec 31, 2023 705,000.00
Sep 30, 2023 1.08 Mn
Jun 30, 2023 1.00 Mn
Mar 31, 2023 1.00 Mn
Dec 31, 2022 257,492.00
Sep 30, 2022 225,000.00